Laurus Labs Limited — Important, 25-07-2025: General Updates

Laurus Labs' board has approved investing up to Euro 5 million in its joint venture, KRKA Pharma Private Limited. The co-venturer will match this with another Euro 5 million, totaling Euro 10 million for the JV. This joint investment aims to establish a new manufacturing facility for finished products, targeting expansion into new markets, including India. This strategic move underscores Laurus Labs' commitment to increasing production capabilities and achieving long-term growth. The JV, incorporated last year, is preparing for operations, signaling future market penetration.